New program aims to protect moms and babies from opioid harm
NCT ID NCT05609669
Summary
This study is testing a new, integrated care program called CADENCE for pregnant women with opioid use disorder. The goal is to use local health data to improve access to treatment and support services for mothers and their babies. Researchers hope this approach will lead to better health outcomes for both mother and child during and after pregnancy.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OPIOID USE DISORDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of South Florida/Tampa General Hospital
Tampa, Florida, 33606, United States
Conditions
Explore the condition pages connected to this study.